Neurohormonal Regulation of Tumor Growth

Abstract

Neurohormones vasopressin and oxytocin are synthesized in the hypothalamus and are transported along the axons to the neurohypophysis as a part of equimolar complexes with hormone-specific neurophysins. The tumors of epithelial origin synthesize ectopic vasopressin and have an ability to express all types of receptors of neurohypophysis hormones. Vasopressin and oxytocin receptors provide the transduction of signals to protein kinases A, B, and C and activate intracellular cascades of the CREB, MDM2, and TORC1/2 proteins and mitogen-activated protein kinases. Central endocrine and autocrine neurohormonal contours are involved in the regulation of proliferative, migration, and angiogenic processes accompanied by tumor progression. Tumor growth and development occur in close cooperation with the supporting stroma. The interstitial tissue is involved in signal communication of tumor cells by integrins and integral CD44 glycoproteins formulating hyaluronic acid. Hyaluronic acid metabolites modulate the effect of neurohormones and peptide growth factors; intermediate hyaluronan fragments with molecular weight of approximately 20 kDa elicit the most significant angiogenic effect. Platelets expressing AVPR1 vasopressin receptors are an important source of hyaluronidase 2 hydrolyzing macromolecular hyaluronan to fragments of intermediate length. The AVPR2 receptors localized in endothelium and AVPR1-AVPR2 vasopressin receptors expressing themselves in the tumor cells are involved in the mechanisms controlling local hemostasis. Neurohormonal regulatory contours are involved in optimization of the balance of inducing and inhibiting signals generated by the tumor and stroma in the process of progressive growth.